Frank Rauch

Active 1994–2024

146
Papers
21,343
Citations
89
h-index
145
i10-index

Citations

Citations per year for Frank Rauch1994: 2 citations1995: 1 citations1996: 3 citations1997: 4 citations1998: 1 citations1999: 3 citations2000: 19 citations2001: 53 citations2002: 59 citations2003: 109 citations2004: 115 citations2005: 125 citations2006: 174 citations2007: 130 citations2008: 242 citations2009: 133 citations2010: 163 citations2011: 151 citations2012: 191 citations2013: 128 citations2014: 196 citations2015: 157 citations2016: 200 citations2017: 142 citations2018: 107 citations2019: 485 citations2020: 603 citations2021: 403 citations2022: 269 citations2023: 168 citations2024: 409 citations2025: 83 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,231 citing papers, 25.5% of this breakdownCanada: 378 citing papers, 7.8% of this breakdownUnited Kingdom: 341 citing papers, 7.1% of this breakdownGermany: 290 citing papers, 6% of this breakdownItaly: 231 citing papers, 4.8% of this breakdownChina: 200 citing papers, 4.2% of this breakdownFrance: 195 citing papers, 4% of this breakdownAustralia: 187 citing papers, 3.9% of this breakdownJapan: 171 citing papers, 3.5% of this breakdownNetherlands: 149 citing papers, 3.1% of this breakdownAustria: 121 citing papers, 2.5% of this breakdownSpain: 108 citing papers, 2.2% of this breakdown
0%25.5%Other 25.4%

Fields

  • Medicine57.1%
  • Biochemistry, Genetics and Molecular Biology34.5%
  • Engineering2.4%
  • Neuroscience1%
  • Psychology1%
  • Nursing0.8%
  • Other3.2%

Topics

  • Bone health and osteoporosis research9.6%
  • Connective tissue disorders research7.7%
  • Bone health and treatments5.4%
  • Bone Metabolism and Diseases4.1%
  • Parathyroid Disorders and Treatments4.1%
  • Bone and Dental Protein Studies3.8%
  • Other65.3%

Coauthors

All papers

Open in search
  1. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism

    Authors: , , , , , , , , , , , , , , - Nature Genetics 2006 cited by 1,198

  2. Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial

    Authors: , , , , , , , , , - Journal of Bone and Mineral Research 2019 cited by 136

  3. Osteogenesis Imperfecta: New Perspectives From Clinical and Translational Research

    Authors: , , - JBMR Plus 2019 cited by 154

  4. Osteogenesis imperfecta

    Authors: , - The Lancet 2004 cited by 1,171

  5. CRTAP Is Required for Prolyl 3- Hydroxylation and Mutations Cause Recessive Osteogenesis Imperfecta

    Authors: , , , , , , , , , , , , , , , , , , , - Cell 2006 cited by 533

  6. Official Positions of the International Society for Clinical Densitometry and Executive Summary of the 2007 ISCD Pediatric Position Development Conference

    Authors: , , , , , , - Journal of Clinical Densitometry 2008 cited by 712

  7. The Determinants of Peak Bone Mass

    Authors: , , , , , , , , - The Journal of Pediatrics 2016 cited by 215

  8. Burosumab for the Treatment of Tumor-Induced Osteomalacia

    Authors: , , , , , , , , , , , - Journal of Bone and Mineral Research 2020 cited by 179

  9. International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions

    Authors: , , , , , , , , , , , , , , , - Bone 2008 cited by 577

  10. Type V Osteogenesis Imperfecta: A New Form of Brittle Bone Disease

    Authors: , , , , , , , , , - Journal of Bone and Mineral Research 2000 cited by 517

  11. Mutations in WNT1 are a cause of osteogenesis imperfecta

    Authors: , , , , , - Journal of Medical Genetics 2013 cited by 196

  12. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia

    Authors: , , , , , , , - Bone 2018 cited by 144

  13. DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum

    Authors: , , , - Osteoporosis International 2016 cited by 155

  14. Approach to the Patient: Pharmacological Therapies for Fracture Risk Reduction in Adults With Osteogenesis Imperfecta

    Authors: , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2023 cited by 37

  15. Osteogenesis Imperfecta Type VI: A Form of Brittle Bone Disease with a Mineralization Defect

    Authors: , , , , , - Journal of Bone and Mineral Research 2002 cited by 444

  16. Reporting whole-body vibration intervention studies: recommendations of the International Society of Musculoskeletal and Neuronal Interactions.

    Authors: , , , , , , , , , - 2010 cited by 338

  17. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years

    Authors: , , , , , , - Journal of Bone and Mineral Research 2015 cited by 139

  18. Recessive Osteogenesis Imperfecta Caused by Missense Mutations in SPARC

    Authors: , , , , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2015 cited by 137

  19. Evidence that Abnormal High Bone Mineralization in Growing Children with Osteogenesis Imperfecta is not Associated with Specific Collagen Mutations

    Authors: , , , , , - Calcified Tissue International 2008 cited by 137

  20. The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review

    Authors: , , , , , , , , , , , , - Orphanet Journal of Rare Diseases 2023 cited by 40

  21. Osteocyte lacunae in transiliac bone biopsy samples across life span

    Authors: , , , , , , , , , , , , , , , , - Acta Biomaterialia 2022 cited by 20

  22. Structural and cellular changes during bone growth in healthy children

    Authors: , , , - Bone 2000 cited by 285

  23. Bone Morbidity and Recovery in Children With Acute Lymphoblastic Leukemia: Results of a Six-Year Prospective Cohort Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2018 cited by 115

  24. Risk factors associated with prevalent vertebral fractures in Duchenne muscular dystrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Osteoporosis International 2022 cited by 25